1 completed. .
Follow Shang Panfeng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients Immunohistochemistry; WB; PCR - Clear Cell Renal Cell Carcinoma (ccRCC) | Completed | Shang Panfeng | 40 | 2024-07-01 | 2025-01-16 |
Carcinogenesis (1) · Carcinoma, Renal Cell (1)
China (1)